![]() |
Contact
Lab: | Prof. Tilman Brummer Independent Research Group Leader |
Department: | Institute of Molecular Medicine and Cell Research |
Address: | Stefan-Meier-Strasse 17 79104 Freiburg |
Phone: | 203 9610 |
E-mail: | This e-mail address is being protected from spambots. You need JavaScript enabled to view it |
Lab homepage: | www.mol-med.uni-freiburg.de/mom-en/brummer |
BIOSS Excellence Cluster: | Member |
PhD positions available: | NO |
Research Area: | Molecular Medicine |
Research Interests: | Our main scientific interest is to understand the mechanisms by which cells convert the information of extracellular signals, e.g. hormones, growth factors or antigens, into intracellular signals and how these events steer physiological and pathological processes such as cancer. |
CV
Education & Training: | 02/2003: awarded PhD in Immunology 1998-02: Ph.D. thesis in Immunology, University of Freiburg, Germany 1997-98: Diploma in Immunology, University of Freiburg, Germany 1992-97: Studies of Biology, University of Freiburg, Germany |
Employment & Experience: | Since 2013: Independent Group leader within the Emmy-Noether-Program of the Deutsche Forschungsgemeinschaft (DFG), Institute for Molecular Medicine and Cell Research, Faculty for Medicine, University of Freiburg 2008-2012: Independent Group leader within the Emmy-Noether-Program of the DFG, Faculty for Biology, University of Freiburg 2003-2008: Postdoctoral fellow, Signal Transduction Group (Prof. R.J. Daly), Cancer Research Program, Garvan Institute of Medical Research, Sydney, Australia 2003: Postdoctoral fellow, Dept. Molecular Immunology (Prof. M. Reth), Max- Planck-Institute for Immunobiology, Freiburg |
Scientific Activities: | Since 2015 Local Faculty (DPI), German Cancer Consortium (DKTK) Since 2015: Member of the Molecular Tumour Board, University Medical Centre Freiburg 2010 – present: Principal Investigator and Executive Board member, Collaborative Research Centre 850 - Control of Cell Motility in Morphogenesis, Cancer Invasion and Metastasis 2008 – present: Principal Investigator, Spemann Graduate School of Biology and Medicine, executive board member since 2012. 2008 – present: Principal Investigator and executive board member, BIOSS. Since 2015 deputy director (Stellvertrender Sprecher) ad hoc reviewer for Nature Medicine, Nature Reviews Drug Discovery, Nature Reviews Immunology, Gastroenterology, EMBO Journal, EMBO reports, Cancer Research, Molecular Cancer Research, Cell Death and Differentiation, Oncogene, Molecular and Cellular Biology, Structure, International Journal of Cancer, Oncotarget, Journal of Biological Chemistry, Biochimica et Biophysica Acta, Cellular Signalling, Molecular Biosystems, FEBS Journal etc. ad hoc reviewer for the Human Frontier Science Program, Medical Research Council (MRC UK), Leukaemia and Lymphoma Research UK, Science Foundation Ireland, Association for International Cancer Research (AICR), National Health and Medical Research Council (NHMRC) of Australia, the Health Research Council (HRC) of New Zealand, the Swiss Cancer League, the Austrian Academy of Science (ÖAW), Deutsche Forschungsgemeinschaft (DFG), Deutsche Krebshilfe (German Cancer Aid) and the Ministry for Art and Science (MWK) Baden-Württemberg. |
Honors
Honors and Awards: | 2015: Heisenberg professorship of the DFG |
Publications
Selected Publications: | Bender, S., Gronych, J., Warnatz, H.J., Hutter, B., Gröbner, S., Ryzhova, M., Pfaff, E., Hovestadt, V., Weinberg, F., Halbach, S., Kool, M., Northcott, P.A., Sturm, D., Bjerke, L., Zichner, T., Stütz, A.M., Schramm, K., Huang, B.D., Buchhalter, I., Heinold, M., Risch, T., Worst, B., van Tilburg, C.M., Weber, U.D., Zapatka, M., Raeder, B., Milford, D., Heiland, S., von Kalle, C., Previti, C., Lawerenz, C., Kulozik, A.E., Unterberg, A., Witt, O., von Deimling, A., Capper, D., Truffaux, N., Grill, J., Jabado, N., Sehested, A.M., Sumerauer, D., Hmida-Ben Brahim, D., Trabelsi, S., Ng, H.-K., Zagzag, D., Allen, J., Karajannis, M.A., Gottardo, N., Jones, C., Korbel, J.O., Schmidt, S., Wolf, S., Reifenberger, G., Felsberg, J., Brors, B., Herold-Mende, C., Lehrach, H., Brummer, T., Korshunov, A., Eils, R., Yaspo, M.-L., Pfister, S.M., Lichter, P. and D.T.W. Jones for the International Cancer Genome Consortium PedBrain Tumor Project (2016). Recurrent MET fusion genes represent a drug target in pediatric glioblastoma. Nature Medicine 22, 1314-1320. Abstract
|
SGBM PhD students
SGBM PhD students: |
Corinna Spohr (01/2018 - 04/2022) Nadine Reischmann (01/2016 - 09/2020) Sebastian Halbach (04/2012 - 04/2016) Martin Köhler (04/2012 - 03/2016) Franziska Wöhrle (08/2008 - 11/2012) Michael Röring (04/2008 - 12/2012) |